Literature DB >> 10771034

Mechanism of histamine release induced by levofloxacin, a fluoroquinolone antibacterial agent.

K Mori1, C Maru, K Takasuna, K Furuhama.   

Abstract

The present study was designed to clarify the mechanism of histamine release caused by levofloxacin, a fluoroquinolone antibacterial agent, using rat peritoneal mast cells. Levofloxacin induced a concentration-dependent histamine secretion from 300 microg/ml without lactate dehydrogenase leakage, and the release was rapidly completed within 30 s. This action was dependent on temperature, energy, pH and intracellular Ca(2+), similarly to the effect of compound 48/80, a basic compound. Unlike that with the calcium ionophore A23187, histamine secretion due to levofloxacin or compound 48/80 was prevented by pretreatment with either pertussis toxin or benzalkonium chloride, a selective inhibitor of G proteins of G(i) subtypes. Moreover, the histamine release elicited by levofloxacin or compound 48/80 was suppressed by hydrolysis of sialic acid residues on the cell surface brought about by neuraminidase. These results demonstrate that the mechanism by which levofloxacin exerts histamine release may be closely linked to activation of pertussis toxin-sensitive G proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771034     DOI: 10.1016/s0014-2999(00)00147-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Mast cell-MrgprB2: sensing secretagogues or a means to overreact?

Authors:  Michele A Grimbaldeston
Journal:  Immunol Cell Biol       Date:  2015-03       Impact factor: 5.126

2.  Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.

Authors:  Liqin Zhu; Yuan Zhang; Jianwei Yang; Yongming Wang; Jianlei Zhang; Yuanyuan Zhao; Weilin Dong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-03-10       Impact factor: 2.441

3.  Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

Authors:  Yan-Ni Mi; Na-Na Ping; Yong-Xiao Cao
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 4.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

5.  Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.

Authors:  Benjamin D McNeil; Priyanka Pundir; Sonya Meeker; Liang Han; Bradley J Undem; Marianna Kulka; Xinzhong Dong
Journal:  Nature       Date:  2014-12-17       Impact factor: 49.962

6.  Magnetic nanoparticle based purification and enzyme-linked immunosorbent assay using monoclonal antibody against enrofloxacin.

Authors:  Nam-Gun Kim; Myeong-Ae Kim; Young-Il Park; Tae-Sung Jung; Seong-Wan Son; ByungJae So; Hwan-Goo Kang
Journal:  J Vet Sci       Date:  2015       Impact factor: 1.672

Review 7.  Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2).

Authors:  Mukesh Kumar; Karthi Duraisamy; Billy-Kwok-Chong Chow
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

8.  Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions.

Authors:  Eri Hamamura-Yasuno; Takuma Iguchi; Kazuyoshi Kumagai; Yoshimi Tsuchiya; Kazuhiko Mori
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.